Studies indicate that GLP-1 medications can adversely impact nutritional health, leading to muscle loss, GI side effects and reduced intake of protein and micronutrients. These issues are key factors contributing to patient discontinuation of the medication. Incorporating high-protein scientifically designed meal replacements into GLP-1 therapy helps improve patient retention by ensuring optimal nutritional intake and promoting long-term health during obesity treatment.
Sign up to get access to our supporting white papers and webinars including:
- White paper: The Clinical Importance of Using Meal Replacements with Anti-Obesity Medication
- White paper: The Efficacy of Meal Replacements for Managing Weight and Jump-Starting Weight Loss in Patients with Obesity
- Webinar: Empowering Sustainable Weight Loss: Integrating Lifestyle and Nutrition for VLCD and GLP-1 Patients – Presented by Katie Chapmon, MS, RD
- Webinar: Utilizing Meal Replacements in Conjunction with GLP-1 Agonists – Presented by Mekhala Chandra, MD
- Webinar: Beyond the Shot (or Pill): Talking with Patients about the Importance of Healthy Dietary Patterns while on GLP-1 Agonist Drugs – Presented by Kristin Kirkpatrick, MS, RDN
Enter your email address to access the information above